Cargando…
ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes
LDL cholesterol (LDL-C) reduction after Acute Coronary Syndromes (ACS) is associated with a significant decrease in subsequent atherosclerotic cardiovascular events. Accordingly, international guidelines recommend a reduction of LDL-C below 70 mg/dL in ACS patients. Such a result can be effectively...
Autores principales: | Colivicchi, Furio, Gulizia, Michele Massimo, Arca, Marcello, Abrignani, Maurizio Giuseppe, Perna, Gian Piero, Mureddu, Gian Francesco, Nardi, Federico, Riccio, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526473/ https://www.ncbi.nlm.nih.gov/pubmed/28751835 http://dx.doi.org/10.1093/eurheartj/sux018 |
Ejemplares similares
-
ANMCO Position Paper: diagnostic–therapeutic pathway in patients with hypercholesterolaemia and statin intolerance
por: Gulizia, Michele Massimo, et al.
Publicado: (2017) -
ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndrome
por: De Luca, Leonardo, et al.
Publicado: (2023) -
ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy
por: Riccio, Carmine, et al.
Publicado: (2017) -
ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives
por: Nardi, Federico, et al.
Publicado: (2017) -
ANMCO Position Paper: hospital discharge planning: recommendations and standards
por: Mennuni, Mauro, et al.
Publicado: (2017)